The 2018 Uwe D. Neue Award in Separation Science was presented to Christopher Pohl of Thermo Fisher Scientific (Sunnyvale, California) during the opening plenary session on Sunday, July 29, at HPLC 2018 in Washington, D.C.
The 2018 Uwe D. Neue Award in Separation Science was presented to Christopher Pohl of Thermo Fisher Scientific (Sunnyvale, California) during the opening plenary session on Sunday, July 29, at HPLC 2018 in Washington, D.C.
Chris Pohl (left) receives the 2018 Uwe Neue Award from Martin Gilar of Waters.
Pohl is the vice president and senior technical advisor for the chromatography team at Thermo Fisher, guiding chemistry R&D in support of ion chromatography, high performance liquid chromatography (HPLC), and gas chromatography. Some of his most significant work includes the development of the accelerated solvent extraction technique, approaches for high pH separation of carbohydrates, the design of ion-exchange chromatography and ion chromatography stationary phases, and triple mixed-mode stationary phases. He has published approximately 120 papers and received 84 U.S. patents.
The Uwe D. Neue Award, sponsored by Waters Corporation (Milford Massachusetts), recognizes scientists that have made and continue to make significant contributions to the field of separation science, in honor of the legacy of Uwe D. Neue, late scientist and Waters Corporate Fellow. The award honors a distinguished industrial scientist, 15–20 years or more after receiving his or her degree, who has made a significant contribution to the field of separation science.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
RP-HPLC to Compare Genotoxic Impurities in Extracted and Synthetic Nicotine
November 7th 2024A recent study examined the impurity profile of thirteen different lots of synthetic nicotine and compared them to fourteen lots of nicotine extracted from plants using in-house analytical methods, with samples tested for alkaloids and phenols with reversed-phase high-performance liquid chromatography (RP-HPLC).